Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?

Clin Vaccine Immunol. 2010 Oct;17(10):1639-41. doi: 10.1128/CVI.00249-10. Epub 2010 Aug 18.

Abstract

We determined the seroprevalence of protective antibodies against Hib in Mexican children under the age of five using a standardized enzyme-linked immunosorbent assay. Hib antibodies (≥ 0.15 μg/ml) were present in 95.34% (±1.14% [seroprevalence ± standard error]) of samples. Fewer children aged 30 to 47 months had protective Hib antibody levels (91.45% ± 2.60%) than children from 12 to 29 and 48 to 59 months (97.3% ± 1.34% and 97.44% ± 1.80%, respectively).

MeSH terms

  • Age Factors
  • Antibodies, Bacterial / blood*
  • Bacterial Capsules / immunology*
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay / methods
  • Enzyme-Linked Immunosorbent Assay / standards
  • Haemophilus Vaccines / immunology*
  • Haemophilus influenzae type b / immunology*
  • Humans
  • Immunization, Secondary / methods
  • Infant
  • Mexico
  • Vaccination / methods*
  • Vaccines, Conjugate / immunology

Substances

  • Antibodies, Bacterial
  • Haemophilus Vaccines
  • Haemophilus influenzae type b polysaccharide vaccine
  • Vaccines, Conjugate